350 related articles for article (PubMed ID: 6426843)
1. Review of auranofin, an oral chrysotherapeutic agent.
Delafuente JC; Osborn TG
Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
[TBL] [Abstract][Full Text] [Related]
2. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
[No Abstract] [Full Text] [Related]
3. Auranofin.
Davis P
Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
[TBL] [Abstract][Full Text] [Related]
4. Single dose pharmacokinetics of auranofin in rheumatoid arthritis.
Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE
J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473
[TBL] [Abstract][Full Text] [Related]
5. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
Bernhard GC
J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
[TBL] [Abstract][Full Text] [Related]
6. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
Goebel KM; Storck U
Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
[TBL] [Abstract][Full Text] [Related]
7. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
8. Gold excretion and retention during auranofin treatment: a preliminary report.
Gottlieb NL
J Rheumatol Suppl; 1979; 5():61-7. PubMed ID: 385875
[TBL] [Abstract][Full Text] [Related]
9. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
10. Auranofin therapy in rheumatoid arthritis.
Bernhard GC
J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
[TBL] [Abstract][Full Text] [Related]
11. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
Batlle Gualda E
Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
[No Abstract] [Full Text] [Related]
12. Auranofin: experience to date.
Blodgett RC
Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601
[TBL] [Abstract][Full Text] [Related]
13. Auranofin: a unique oral chrysotherapeutic agent.
Blodgett RC; Heuer MA; Pietrusko RG
Semin Arthritis Rheum; 1984 Feb; 13(3):255-73. PubMed ID: 6427927
[TBL] [Abstract][Full Text] [Related]
14. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
[TBL] [Abstract][Full Text] [Related]
15. Auranofin (Ridaura).
Med Lett Drugs Ther; 1985 Oct; 27(699):89-90. PubMed ID: 3932827
[No Abstract] [Full Text] [Related]
16. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
[TBL] [Abstract][Full Text] [Related]
17. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
Batlle Gualda E
Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
[No Abstract] [Full Text] [Related]
18. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
Furst DE
Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
[TBL] [Abstract][Full Text] [Related]
19. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
Davis P; Menard H; Thompson J; Harth M; Beaudet F
J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
